Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis
Abstract:
Incubation of human myelin at neutral pH resulted in the proteolytic conversion of the myelin-associated glycoprotein to a lower molecular weight derivative (dMAG) and the degradation of basic protein. The formation of dMAG occurred much more rapidly than the degradation of basic protein. The formation of dMAG and the degradation of basic protein both occurred significantly more rapidly in myelin preparations purified from brains of patients with multiple sclerosis than in preparations from control brain. The results suggest that this neutral protease associated with myelin may function in the pathogenesis of demyelinating diseases such as multiple sclerosis.
Insights
A neutral protease in human myelin degrades myelin proteins, forming a derivative of myelin-associated glycoprotein (dMAG) and basic protein. This process accelerates in multiple sclerosis, suggesting a role in demyelinating diseases.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Myelin is crucial for nerve insulation and function.
- Demyelinating diseases, like multiple sclerosis (MS), involve myelin damage.
- The molecular mechanisms underlying myelin degradation in MS are not fully understood.
Purpose of the Study:
- To investigate the proteolytic activity within human myelin.
- To determine if myelin-associated enzymes contribute to demyelination.
- To explore the potential role of myelin proteases in the pathogenesis of multiple sclerosis.
Main Methods:
- Incubation of human myelin at neutral pH.
- Analysis of myelin protein degradation products using molecular weight determination.
- Comparison of proteolytic activity in myelin from control subjects versus patients with multiple sclerosis.
Main Results:
- Proteolytic conversion of myelin-associated glycoprotein (MAG) to a lower molecular weight derivative (dMAG) was observed.
- Degradation of basic protein also occurred.
- Both dMAG formation and basic protein degradation were significantly faster in myelin from MS patients compared to controls.
- dMAG formation was more rapid than basic protein degradation.
Conclusions:
- A neutral protease associated with human myelin can degrade key myelin components.
- The accelerated activity of this protease in MS myelin suggests its involvement in the disease process.
- This myelin-associated neutral protease may play a role in the pathogenesis of demyelinating diseases such as multiple sclerosis.
